Author Archives: Maureen Newman

Parkinson’s Disease Shows Signs of Mitochondrial Dysfunction

A recent literature review revealed that mitochondria may play a role in the second most common neurodegenerative disorder: Parkinson’s disease (PD). The review was published in the International Journal of Molecular Sciences and is entitled “Mitochondria: A Therapeutic Target for Parkinson’s Disease?“.

Myofibrillar Myopathies Characterized by Mitochondrial Dysfunction

Muscle disorders (myofibrillar myopathies) can sometimes be caused by genetic mutations in genes related to proteins in muscle bands, but other times, myofibrillar myopathies are caused by mitochondrial dysfunction. According to a research team from the Departments of Neurology and Pathology at Technische Universität Dresden in Germany, different subtypes of…

NeuroVive Awaiting Topline Results of CIRCUS Trial with CicloMulsion

NeuroVive Pharmaceutical AB (publ), the mitochondrial medicine company, is currently conducting a Phase III clinical study (“CIRCUS”) with its lead candidate CicloMulsion® in patients with ST-segment elevation acute myocardial infarction (STEMI). Topline results are expected in this quarter, which is sooner than expected, and will determine the success of meeting…

Stem Cell Transplant Studied in MNGIE

A currently-recruiting Phase 1 clinical trial will identify if stem cell transplants are a safe treatment option for the rare disease mitochondrial neurogastrointestinal encephalopathy syndrome (MNGIE). The study aims to recruit 12 patients with MNGIE and treat them with allogeneic hematopoetic stem cells collected from the bone marrow or blood…